Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy (OPTILIV)
This study is currently recruiting participants.
Verified February 2011 by Association pour la Recherche sur le Temps Biologique et la Chronothérapie
Sponsor:
Association pour la Recherche sur le Temps Biologique et la Chronothérapie
Collaborators:
Institut Gustave Roussy
Merck Serono International SA
Pfizer
CRESGE
Information provided by:
Association pour la Recherche sur le Temps Biologique et la Chronothérapie
ClinicalTrials.gov Identifier:
NCT00852228
First received: February 25, 2009
Last updated: February 4, 2011
Last verified: February 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |